Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Christiansen

Showing results (11-20 of 194) with videos related to

Pageof 20
Sort By:
Menopause (New York, N.Y.)|May 9, 2009
Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trialMatthias Schaefers, Christoph Muysers, Peter Alexandersen, et al.
Women'S Health (London, England)|October 7, 2009
The clinical potential of estrogen for the prevention of osteoarthritis: what is known and what needs to be done?László B Tankó, Morten A Karsdal, Claus Christiansen
American Journal of Obstetrics and Gynecology|October 22, 2002
Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A reviewBente Juel Riis, Hans-Jørgen Lehmann, Claus Christiansen
Journal of Alzheimer'S Disease : JAD|August 30, 2014
Relationship between serum levels of tau fragments and clinical progression of Alzheimer's diseaseKim Henriksen, Inger Byrjalsen, Claus Christiansen, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|July 30, 2013
Musculoskeletal ageing and primary preventionAnders Nedergaard, Kim Henriksen, Morten A Karsdal, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 17, 2008
Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone qualityMorten A Karsdal, Kim Henriksen, Michel Arnold, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 7, 2013
Menopause, estrogens and frailtyAnders Nedergaard, Kim Henriksen, Morten Asser Karsdal, et al.
Maturitas|December 22, 2005
Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled studyTherese F Nielsen, Pernille Ravn, Joan Pitkin, et al.
Bone|June 1, 2019
Low bone turnover levels predict increased risk of cancerCecilie Liv Bager, Frederikke Bay, Claus Christiansen, et al.
Menopause (New York, N.Y.)|May 29, 2004
Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal womenLise Warming, Pernille Ravn, Danièle Spielman, et al.
Pageof 20

Showing results (11-20 of 194) with videos related to

Sort By:
Pageof 20
Menopause (New York, N.Y.)|May 9, 2009
Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trialMatthias Schaefers, Christoph Muysers, Peter Alexandersen, et al.
Women'S Health (London, England)|October 7, 2009
The clinical potential of estrogen for the prevention of osteoarthritis: what is known and what needs to be done?László B Tankó, Morten A Karsdal, Claus Christiansen
American Journal of Obstetrics and Gynecology|October 22, 2002
Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A reviewBente Juel Riis, Hans-Jørgen Lehmann, Claus Christiansen
Journal of Alzheimer'S Disease : JAD|August 30, 2014
Relationship between serum levels of tau fragments and clinical progression of Alzheimer's diseaseKim Henriksen, Inger Byrjalsen, Claus Christiansen, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|July 30, 2013
Musculoskeletal ageing and primary preventionAnders Nedergaard, Kim Henriksen, Morten A Karsdal, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 17, 2008
Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone qualityMorten A Karsdal, Kim Henriksen, Michel Arnold, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 7, 2013
Menopause, estrogens and frailtyAnders Nedergaard, Kim Henriksen, Morten Asser Karsdal, et al.
Maturitas|December 22, 2005
Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled studyTherese F Nielsen, Pernille Ravn, Joan Pitkin, et al.
Bone|June 1, 2019
Low bone turnover levels predict increased risk of cancerCecilie Liv Bager, Frederikke Bay, Claus Christiansen, et al.
Menopause (New York, N.Y.)|May 29, 2004
Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal womenLise Warming, Pernille Ravn, Danièle Spielman, et al.
Pageof 20